pharmaphorum1y
Lilly adds to non-opioid pain pipeline with Confo deal
Almost two years after finally pulling the plug on a big non-opioid painkiller programme, Eli Lilly has ... royalty rate. Lilly’s last attempt to develop a non-opioid pain drug was with Pfizer ...
Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
pharmaphorum7d
Lilly says Mounjaro launch is "viral in nature"
One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been ...
Yahoo1mon
FDA approves Zepbound for obstructive sleep apnea
According to drugmaker Eli Lilly, it’s the first and only FDA-approved ... constipation and stomach pain. Some users have developed pancreatitis or inflammation of the pancreas, others have ...
Yahoo Finance21d
Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get them
Obesity is a major global health crisis, especially in the United States, but newer weight-loss drugs like Eli Lilly’s (LLY) Zepbound could offer a long-awaited solution — if they become more ...
Hosted on MSN1mon
Merck’s weight-loss pill deal: what it means for Eli Lilly
Some experts even expect Eli Lilly to be the world’s first healthcare company to hit $1.00 trillion valuation on the back of its weight-loss initiative. What the licensing deal means for Merck ...
Wall Street Journal7d
Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...